The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
23andMe Holding Co. COM CL A 90138Q108 8,183 700,000 SH   SOLE   700,000 0 0
Aclaris Therapeutics, Inc. COM 00461U105 22,095 1,258,243 SH   SOLE   1,258,243 0 0
ALX Oncology Holdings Inc. COM 00166B105 12,642 231,200 SH   SOLE   231,200 0 0
BCTG Acquisition Corp. COM 05492W103 4,552 400,000 SH   SOLE   400,000 0 0
Cullinan Oncology, Inc. COM 230031106 70,334 2,731,410 SH   SOLE   2,731,410 0 0
FS Development Corp. II COM CL A 30318F100 6,013 602,500 SH   SOLE   602,500 0 0
Gemini Therapeutics, Inc. COM 36870G105 15,755 2,435,125 SH   SOLE   2,435,125 0 0
Helix Acquisition Corp. COM CL A G4444C102 2,588 250,000 SH   SOLE   250,000 0 0
Hims & Hers Health, Inc. COM CL A 433000106 11,510 1,056,922 SH   SOLE   1,056,922 0 0
Kinnate Biopharma Inc. COM 49705R105 20,370 875,001 SH   SOLE   875,001 0 0
Lucira Health, Inc. COM 54948U105 3,220 485,000 SH   SOLE   485,000 0 0
Nurix Therapeutics, Inc. COM 67080M103 11,979 451,522 SH   SOLE   451,522 0 0
Pharvaris N.V. COM N69605108 6,784 364,142 SH   SOLE   364,142 0 0
Population Health Investment Co., Inc. UNIT G71716123 9,744 960,000 SH   SOLE   960,000 0 0
Quantum-Si Incorporated COM CL A 74765K105 28,714 2,342,061 SH   SOLE   2,342,061 0 0
Relay Therapeutics, Inc. COM 75943R102 14,636 400,000 SH   SOLE   400,000 0 0
Research Alliance Corp. II COM CL A 760873109 5,070 500,000 SH   SOLE   500,000 0 0